Use of lipid‐lowering therapies in patients with chronic kidney disease and atherosclerotic cardiovascular disease: 2‐year results from G etting to an impr O ved U nderstanding of L ow‐ D ensity lipoprotein cholesterol and dyslipidemia management ( GOULD )-Reference-Cited by-同舟云学术

Use of lipid‐lowering therapies in patients with chronic kidney disease and atherosclerotic cardiovascular disease: 2‐year results from G etting to an impr O ved U nderstanding of L ow‐ D ensity lipoprotein cholesterol and dyslipidemia management ( GOULD )

Published:2022-09-19 Issue:12 Volume:45 Page:1303-1310
ISSN:0160-9289
Container-title:Clinical Cardiology
language:en
Short-container-title:Clinical Cardiology

Author:

Shaik Aleesha¹^ORCID,Kosiborod Mikhail²³,de Lemos James A.⁴,Gao Qi⁵,Mues Katherine E.⁶,Alam Shushama⁶,Bhatt Deepak L.⁷,Cannon Christopher P.⁷⁵^ORCID,Ballantyne Christie M.⁸,Rosenson Robert S.¹,

Affiliation:

1. The Cardiometabolic Disorders Unit Icahn School of Medicine at Mount Sinai New York New York USA

2. Saint Luke's Mid America Heart Institute University of Missouri‐Kansas City Kansas City Missouri USA

3. The George Institute for Global Health University of New South Wales Sydney Australia

4. Division of Cardiology University of Texas Southwestern Medical Center Dallas Texas USA

5. Baim Institute for Clinical Research Boston Massachusetts USA

6. Amgen Inc. Thousand Oaks USA

7. Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School Boston Massachusetts USA

8. Department of Medicine Baylor College of Medicine Houston Texas USA

Funder

Amgen

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/clc.23923

Reference21 articles.

1. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study

2. Centers for Disease Control and Prevention. Chronic Kidney Disease Surveillance System website. Accessed February 19 2021.https://nccd.cdc.gov/CKD

3. Observational multicenter study to evaluate the prevalence and prognosis of subclinical atheromatosis in a Spanish chronic kidney disease cohort: baseline data from the NEFRONA study

4. U.S. Renal Data System USRDS. 2002 Annual Data Report: Atlas of End‐Stage Renal Disease in the United States Bethesda Md National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health.2002.

5. BaigentC BurburyK WheelerD.Premature cardiovascular disease in chronic renal failure.Lancet.2000:356147‐356152.